2495 General Armistead Avenue ● Norristown, Pennsylvania 19403 ● USA ● Tel: +1 (610) 539-3670 ● Fax: +1 (610) 539-3831
Norristown, Pennsylvania, 4 June 2014
PluroGen Therapeutics, Inc., leading solutions for wound, burn and skin care with its advanced PluroGel® Biomaterial surfactant products, announced today that a new patent has been issued by Australia to protect its Polysaccharide Natural Gel Technology. With this patent, PluroGen’s Australia patent protection is extended to 2027.
The Polysaccharide Natural Gel Technology will be used for the Company’s next generation PluroGel® Products, providing clinically important new features for the PluroGel® line. Additionally, the Polysaccharide Natural Gel Technology holds the potential for a new line of products addressing new markets for the Company.
“Obtaining patent protection for our Polysaccharide Natural Gel Technology products in Australia is an important milestone for the Company strengthening our intellectual property portfolio and our future market launch position in the Australian market” commented Neal Koller, PluroGen President & CEO. “Our PluroGel® Products are already achieving superior patient results and adding the properties of the Polysaccharide Natural Gel Technology is expected to give the Company’s products an additional and important edge in the Australian market place.
For Immediate Release
Contact: Neal Koller
President & CEO
+1 (610) 539‐3670